GB2265311B
(en )
1994-02-09
Sustained release formulations of water soluble peptides
PH30995A
(en )
1997-12-23
Sustained release formulations of water soluble peptides.
IL87790A
(en )
1992-05-25
Sustained release compositions containing water insoluble polypeptides
GB2230185B
(en )
1993-05-12
Sustained release pharmaceutical compositions
ZA907492B
(en )
1991-10-30
Stabilized aqueous formulations of small peptides
ZA904925B
(en )
1992-02-26
Sustained release pharmaceutical compositions
GB2195893B
(en )
1991-05-08
Sustained release pharmaceutical compositions
GB8812928D0
(en )
1988-07-06
Contraceptive methods & compositions
AP9000174A0
(en )
1990-04-30
Antiparasitical formulations
IL88148A0
(en )
1989-06-30
Somatotropin sustained release formulations
CY1844A
(en )
1996-03-08
Sustained release formulations of water soluble peptides
ZA905327B
(en )
1992-03-25
Sustained release formulations of water soluble peptides
GB2237839B
(en )
1994-05-11
Powered release of connectors
IL131881A0
(en )
2001-03-19
Sustained release formulation comprising octreotide
IE890932L
(en )
1989-09-25
Water soluble ibuprofen compositions
IE871503L
(en )
1987-12-06
Sustained release formulations
GB8922061D0
(en )
1989-11-15
Controlled release formulations
ZA898470B
(en )
1990-07-25
Sustained release preparations
IE893777L
(en )
1990-05-30
Sustained release diltiazen formulation
GB8904109D0
(en )
1989-04-05
New formulations of chloramine
IE880658L
(en )
1988-09-09
Sustained release compositions
GB8624214D0
(en )
1986-11-12
Sustained release pharmaceutical compositions
IE862339L
(en )
1987-03-03
Disc-like sustained release formulations
NZ234086A
(en )
1993-08-26
Preparation of tripeptide aldehydes
GB8908838D0
(en )
1989-06-07
Sustained release